Lung Resistance Protein and Multidrug Resistance Protein in Non-small Cell Lung Cancer and Their Clinical Significance

Author： Chen ZJ Le HB Zhang YK Qian LY Sekhar K Raja Li WD

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.5, 2011-09, pp. : 1693-1700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells

By Salerno M. Garnier-Suillerot A.

European Journal of Pharmacology, Vol. 421, Iss. 1, 2001-06 ,pp. : 1-9

Elsevier

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

By Park In Kim Jin Jung Jae Han Ji-Youn

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 791-799

Springer Publishing Company

Access to resources Recommend Favorite

Silencing of X-linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel But Not Gemcitabine in Non-small Cell Lung Cancer

By Liu Y Wu X Sun Y Chen F

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1682-1692

Field House Publishing

Access to resources Recommend Favorite

ALK-positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

By Steuer Conor E. Ramalingam Suresh S.

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2392-2402

Blackwell Publishing

Access to resources Recommend Favorite